• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTAWIRE DRIVE; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTAWIRE DRIVE; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Model Number 2077-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation of Vessels (2135); Unspecified Tissue Injury (4559)
Event Date 01/07/2022
Event Type  Injury  
Event Description
It was reported that a perforation occurred.The 95% target lesion was located in the left anterior descending artery (lad).A rotawire drive guide wire was selected for use.There was no observed damage to the wire.During removal the rotawire the rotawire became entangled with the vascular tissue and a vascular perforation was observed.The perforated area was treated with another company's balloon catheter.The procedure was completed and no further patient complications were reported.
 
Manufacturer Narrative
Device evaluated by manufacturer: returned product consisted of the rotawire drive.The wire body, proximal end, and spring tip were visually and microscopically examined.Inspection of the device found that the spring tip was kinked and stretched.Tissue was identified on the wire body, but the exact nature of the tissue was unable to be determined.Functional testing consisted of using a test rotablator device, as the device used in the procedure was not returned.During functional testing, the returned rotawire was able to be inserted through the annulus of the burr and advanced through the advancer before being removed with no resistance or issues.Product analysis confirmed the reported interaction with vessel tissue, as tissue was identified on the device upon receipt.The reported vessel perforation could not be confirmed as clinical circumstances could not be replicated.
 
Event Description
It was reported that a perforation occurred.The 95% target lesion was located in the left anterior descending artery (lad).A rotawire drive guide wire was selected for use.There was no observed damage to the wire.During removal the rotawire the rotawire became entangled with the vascular tissue and a vascular perforation was observed.The perforated area was treated with another company's balloon catheter.The procedure was completed and no further patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTAWIRE DRIVE
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13334091
MDR Text Key284300201
Report Number2134265-2022-00569
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P900056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/20/2023
Device Model Number2077-01
Device Catalogue Number2077-01
Device Lot Number0027698472
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/26/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/07/2022
Initial Date FDA Received01/24/2022
Supplement Dates Manufacturer Received02/14/2022
Supplement Dates FDA Received02/17/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-